Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Insulin Degludec vs Insulin Glargine for Glycemic Control in Critical Illness Hyperglycemia

NCT06178874 is registered in ClinicalTrials.gov with Ain Shams University as lead sponsor.

NCT NCT06178874
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06178874 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Insulin Degludec vs Insulin Glargine for Glycemic Control in Critical Illness Hyperglycemia
Lead sponsor
Ain Shams University
Phase
Not applicable
Overall status
Completed
Start date
December 1, 2023
Completion date
June 1, 2024
Enrollment
90 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

critical illness, glycemic control, insulin